Newsletter | August 20, 2025

08.20.25 -- You Just Secured $50 Million. Now On To The Hard Part: Clinical Trials

TRIAL MANAGEMENT

You Just Secured $50 Million. Now On To The Hard Part: Clinical Trials

4C Associates' life sciences director Tom Wells explores common pitfalls of early-stage biotechs' transition into clinical trials and shows how early involvement of sourcing professionals can improve delivery, control spend, and help retain oversight.

Blueprint For Early Phase Clinical Pharmacology Studies In Dermatology

Explore the landscape of dermatological drug development through a comprehensive framework for rational early-phase dermatological trials, centered around five foundational pillars.

How Digitized Protocols Are Accelerating Clinical Research

Digitized protocols, enhanced by artificial intelligence (AI), are transforming clinical trial operations by accelerating document generation, system integration, and trial optimization.

Why Human Insight Remains Essential In The Age Of AI

In an age defined by the allure of AI-driven automation and big data analytics, organizations often mistake technological adoption for innovation.

Balance Innovation With Operational Excellence In Oncology Trials

Experts discuss how to navigate the complexities of adaptive trial designs and how ethics reviews uphold patient safety, ensure informed consent, and provide robust oversight.

Reimagining How You Bring Life-Changing Therapies To Patients

Accelerate your therapy's path to market and create better experiences with the right partner to provide end-to-end Clinical Development expertise.

Gain Instant Access To HEOR Education With On-Demand Programs

The ISPOR Education Center provides instant access to Health Economics and Outcomes Research education with on-demand programs delivered through a personalized and flexible learning platform.

Combining Automation And Human Expertise For Custom Kitting

While automated inventory management systems play a crucial role in tracking samples, kit availability, and supply levels human involvement is still important to the adaptability of a clinical trial.

DECENTRALIZED TRIALS

Can Digital Endpoints Really Accelerate Clinical Trials?

Digital biomarkers are quickly and quietly becoming the digital revolution needed to make clinical trials quicker and more data rich.

Optimizing Oncology And Rare Disease Clinical Trials

Dive into the history and accomplishments of Ergomed, a mid-sized, full-service contract research organization (CRO), with a specialized focus on oncology and rare disease clinical research.

Beyond the Checkbox: Rethinking Your Cardiac Monitoring Approach

A modernized approach to cardiac monitoring is essential for the dynamic nature of contemporary clinical trials, which demand flexibility, remote capabilities, and real-time data access.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: